,使CD70CAR-T

Corynn Kasap1, Adila Izgutdina1, Bonell Patiño-Escobar1

  • 1University of California San Francisco, San Francisco, California, United States.

Blood
|May 13, 2025
PubMed
概括

研究人员将CD70确定为高风险多发性骨髓瘤的新目标. 针对CD70的基于CD27的新CAR-T疗法显示出优异的扩张和克服治疗耐药性的潜力.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K